Facebook
X
LinkedIn
ForwardPower Up Your Interventional Pain Management Coding Series
This activity is designed for learners to increase knowledge of how to choose, apply and correctly code for Interventional Pain Management.
Target Audience
This activity is designed for an audience of Physicians, Non-Physician Providers, Billing Managers, Coding/Billing Staff, Administrators, and Revenue Cycle Directors.
Learning Objectives
- Define documentation risk areas and understand how to avoid them.
- Choose appropriate codes and modifiers for interventional procedures for spine, joint, soft tissue, tendon, and nerve block injections.
- Comply with pain coding and payor rules.
- Apply use of interventional pain coverage policies to the reimbursement workflow.
- Apply coding rules and principles for reporting E/M and in office procedures for services to avoid audits.
- Review ICD-10-CM coding related to pain management.
- Correctly bill for Advance Practice Provider (APP) Medicare services.
Commercial Support
There is no commercial support for this activity.
AKH Inc. and KarenZupko & Associates, Inc staff and reviewers have no financial relationships with ineligible companies to disclose.
Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and KarenZupko & Associates, Inc. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 6.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 6.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.50 AAPA Category 1 CME credits. Approval is valid until 11/1/2026. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 6.50 AAPA Category 1 CME
- 6.50 AMA PRA Category 1 Credit™
- 6.50 Attendance